Posted in | News | Green Products

DMC Biotech Completes Successful Pilot of L-Alanine

DMC Biotechnologies has successfully produced its lead product, L-alanine at pilot scale. Commercial key performance metrics were achieved and performance from the bench scale was also demonstrated at 3m3scale fermentation and for each of the downstream purification unit operations. The robustness of DMC’s Dynamic Metabolic Control technology to the process environment was also validated.

The predictability of the DMC process has been demonstrated from high throughput screening to commercially relevant scale. Kilogram-sized samples of on-specification product are currently being provided to potential customers, paving the way to commercial launch later this year. No further strain improvement or process engineering is required.

During the execution of the fermentation, a technical failure of an inlet valve in the pilot plant resulted in a material deviation from the protocol. This type of mechanical issue is commonplace in the real world of industrial fermentation. The DMC strain and process were not materially affected by this deviation and the target metrics were still achieved because of the robustness of the technology and the timely response by BPF’s operators. In contrast, most of the current bioprocesses today would have been un-recoverable to this type of deviation.

Raimo van der Linden, Business Development Manager, Bioprocess Pilot Facility (BPF) said, “We recreate real life industrial conditions at BPF and help companies such as DMC validate their technology at pilot scale. The robustness of DMC’s process was thoroughly challenged during this work. The demonstration of robustness to the process environment is truly game-changing for the field of industrial biotechnology."

Matt Lipscomb, Ph.D., CEO & Co-Founder of DMC said, “Successful pilot scale production is an important step towards full commercialization of L-alanine which will happen later this year. We knew our Dynamic Metabolic Control process was robust. It has been further proven through real-world operating conditions at BPF’s pilot plant.”

See the video press release at https://youtu.be/UvJAyllodRo

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    DMC Biotechnologies, Inc.. (2020, February 08). DMC Biotech Completes Successful Pilot of L-Alanine. AZoCleantech. Retrieved on November 21, 2024 from https://www.azocleantech.com/news.aspx?newsID=26986.

  • MLA

    DMC Biotechnologies, Inc.. "DMC Biotech Completes Successful Pilot of L-Alanine". AZoCleantech. 21 November 2024. <https://www.azocleantech.com/news.aspx?newsID=26986>.

  • Chicago

    DMC Biotechnologies, Inc.. "DMC Biotech Completes Successful Pilot of L-Alanine". AZoCleantech. https://www.azocleantech.com/news.aspx?newsID=26986. (accessed November 21, 2024).

  • Harvard

    DMC Biotechnologies, Inc.. 2020. DMC Biotech Completes Successful Pilot of L-Alanine. AZoCleantech, viewed 21 November 2024, https://www.azocleantech.com/news.aspx?newsID=26986.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.